87 results
Page 3 of 5
8-K
EX-99.1
b8v12si 5j1t2iehifgn
29 Jun 23
Immunome and Morphimmune Announce Definitive Merger Agreement
9:08am
8-K
EX-99.1
uxtwgnp3gcm6hdf pop
5 May 23
Immunome Reports First Quarter 2023 Financial Results
8:19am
8-K
EX-99.1
q0f75i6ffl weeoxxwz0
15 Nov 22
Other Events
4:17pm
8-K
EX-99.1
1rtsiuo h4unu25
14 Nov 22
Immunome Reports Third Quarter 2022 Financial Results
9:06am
8-K
EX-99.1
aidbiscqsa 15
5 Aug 22
Immunome Reports Second Quarter 2022 Financial Results
8:15am
8-K
EX-99.1
ywl fao3hi
6 Jul 22
Other Events
5:15pm
8-K
EX-99.1
lqgkvdz
9 Jun 22
Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
8:32am
8-K
EX-99.2
z8el7lod
9 Jun 22
Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
8:32am
8-K
EX-99.1
o1xqtmcg1emzk6
19 May 22
Other Events
4:05pm
8-K
EX-99.1
1ra6wm9s83ya wy
12 May 22
Immunome Reports First Quarter 2022 Financial Results
8:34am
8-K
EX-99.1
vtr7ir8lgw 18ki
28 Mar 22
Immunome Reports Fourth Quarter and Full Year 2021 Financial Results
8:14am
8-K
EX-99.1
prb6c02mld4d7cxtyd
11 Mar 22
FDA Lifts Clinical Hold on Immunome’s IMM-BCP-01 IND Application for the Treatment of COVID-19
2:33pm
8-K
EX-99.1
ui56bg7sxfr ci
8 Feb 22
Other Events
8:27am
8-K
EX-99.1
456xkuii1khle6p
10 Jan 22
Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19
4:52pm
8-K
EX-99.1
pw60pi01dhcow
29 Nov 21
Immunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19
7:14am